Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
This study has been completed.
Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Information provided by:
Sanwa Kagaku Kenkyusho Co., Ltd.
ClinicalTrials.gov Identifier:
NCT00334503
First received: June 5, 2006
Last updated: October 8, 2008
Last verified: October 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
Condition | Intervention | Phase |
---|---|---|
Type 2 Diabetes Mellitus |
Drug: Miglitol |
Phase 3 |
Study Type: | Interventional |
Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Sanwa Kagaku Kenkyusho Co., Ltd.:
Eligibility
Ages Eligible for Study: | 20 Years to 69 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Type 2 diabetic patients with Biguanide treatment
- Criteria for postprandial plasma glucose and HbA1c are met
Exclusion Criteria:
- Type 1 diabetes
- Patients treated with other antidiabetic drugs or Insulin
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00334503
Locations
Japan | |
Aichi, Japan | |
Chiba, Japan | |
Fukuoka, Japan | |
Gunma, Japan | |
Hokkaido, Japan | |
Ibaragi, Japan | |
Kagoshima, Japan | |
Kanagawa, Japan | |
Kumamoto, Japan | |
Miyazaki, Japan | |
Oita, Japan | |
Osaka, Japan | |
Saitama, Japan |
Sponsors and Collaborators
Sanwa Kagaku Kenkyusho Co., Ltd.
Investigators
Study Director: | Clinical Study Group, Clinical Development Dept. | Sanwa Kagaku Kenkyusho Co., Ltd. |
More Information
No publications provided
Keywords provided by Sanwa Kagaku Kenkyusho Co., Ltd.:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 16, 2012
No publications provided
ClinicalTrials.gov Identifier: | NCT00334503 History of Changes |
Other Study ID Numbers: | MG1009 |
Study First Received: | June 5, 2006 |
Last Updated: | October 8, 2008 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Keywords provided by Sanwa Kagaku Kenkyusho Co., Ltd.:
alpa-glucosidase inhibitor,Biguanide |
Additional relevant MeSH terms:
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Miglitol |
Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Hypoglycemic Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on October 16, 2012